🔗 Visit the ClinicalTrials.gov page for NCT01882179
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. | N Engl J Med | 1999 | 29.32 |
| 2 | Eplerenone in patients with systolic heart failure and mild symptoms. | N Engl J Med | 2010 | 14.43 |
| 3 | Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. | N Engl J Med | 2003 | 13.25 |
| 4 | Cardioprotective effects of mineralocorticoid receptor antagonists at reperfusion. | Eur Heart J | 2009 | 1.03 |
| 5 | Autophagy, a process within reperfusion injury: an update. | Int J Clin Exp Pathol | 2014 | 0.84 |
| 6 | Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design. | Clin Cardiol | 2015 | 0.75 |